University Hospital, Gentofte, Copenhagen: Diabetes Mellitus, Type 2 trials

The registry lists 25 Diabetes Mellitus, Type 2 studies with University Hospital, Gentofte, Copenhagen as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 2 2Phase 3 2Phase 4 2No phase 20(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 DiabetesCompletedNCT00411411Phase 3Results posted
• The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 DiabetesCompletedNCT00321321Phase 2Results posted
• The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 DiabetesCompletedNCT04228484Not applicable
• Effect of GIP After a Meal in Patients With Type 2 DiabetesCompletedNCT03702660Not applicable
• GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food IntakeCompletedNCT03526289Not applicable
• Hypoglycaemia and Cardiac Arrhythmias in Type 2 DiabetesCompletedNCT03150030
• The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without SulphonylureaCompletedNCT03081676Not applicable
• Anatomical and Physiological Characterisation of the Gut Endocrine Cells in Healthy and in Patients With Type 2 DiabetesCompletedNCT03044860Not applicable
• The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 SecretionCompletedNCT03018444Not applicable
• Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 DiabetesCompletedNCT02669524Not applicable
• Shared Care for Patients With Type 2 Diabetes Across the Primary and Secondary Health Care SectorCompletedNCT02586545Not applicable
• Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 DiabetesCompletedNCT02497313Not applicable
• Effect of Bile Acid Secretion and Sequestration on GLP-1 SecretionCompletedNCT02445508Not applicable
• Correlation Between Plasma- and Endothelial DPP-4 ActivityCompletedNCT02192853Phase 4
• Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose InfusionCompletedNCT02010827
• Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes MellitusCompletedNCT01689051Not applicable
• Effect of Bile Acids on GLP-1 SecretionCompletedNCT01666223Not applicable
• The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)CompletedNCT01610934Phase 2/3
• Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)CompletedNCT01342939
• Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes MellitusCompletedNCT00923962Not applicable
• Incretin Effect in Lean and Obese SubjectsCompletedNCT00803296
• Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes MellitusStatus unknownNCT00655603Not applicable
• The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic HyperglucagonemiaCompletedNCT00639613
• The Incretin Effect in Patients With Chronic PancreatitisCompletedNCT00638573
• Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.Status unknownNCT00254085Phase 4